The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data
Author
Abstract
Suggested Citation
DOI: 10.1080/10438599.2013.828456
Download full text from publisher
As the access to this document is restricted, you may want to look for a different version below or
for a different version of it.Other versions of this item:
- Frank Lichtenberg & Billie Pettersson, 2012. "The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data," CESifo Working Paper Series 3894, CESifo.
References listed on IDEAS
- Lichtenberg Frank R., 2010.
"Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia,"
Forum for Health Economics & Policy, De Gruyter, vol. 13(2), pages 1-18, August.
- Frank R. Lichtenberg, 2010. "Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia," NBER Working Papers 16051, National Bureau of Economic Research, Inc.
- Productivity Commission, 2005. "Impacts of Advances in Medical Technology in Australia," Research Reports, Productivity Commission, Government of Australia, number 17, January.
- Gene M. Grossman & Elhanan Helpman, 1991.
"Quality Ladders in the Theory of Growth,"
The Review of Economic Studies, Review of Economic Studies Ltd, vol. 58(1), pages 43-61.
- Gene M. Grossman & Elhanan Helpman, 1989. "Quality Ladders in the Theory of Growth," NBER Working Papers 3099, National Bureau of Economic Research, Inc.
- Grossman, G.M. & Helpman, E., 1989. "Quality Ledders In The Theory Of Growth," Papers 148, Princeton, Woodrow Wilson School - Public and International Affairs.
- Lichtenberg Frank R., 2013.
"The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files,"
Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 1-33, January.
- Frank R. Lichtenberg, 2012. "The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files," NBER Working Papers 18552, National Bureau of Economic Research, Inc.
- Frank Lichtenberg, 2012. "Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7," PharmacoEconomics, Springer, vol. 30(3), pages 197-211, March.
- Lichtenberg, Frank R., 2013.
"The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000–2007,"
Social Science & Medicine, Elsevier, vol. 77(C), pages 50-59.
- Frank R. Lichtenberg, 2011. "The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007," NBER Working Papers 17414, National Bureau of Economic Research, Inc.
- Kevin M. Murphy & Robert H. Topel, 2006.
"The Value of Health and Longevity,"
Journal of Political Economy, University of Chicago Press, vol. 114(5), pages 871-904, October.
- Kevin M. Murphy & Robert H. Topel, 2005. "The Value of Health and Longevity," NBER Working Papers 11405, National Bureau of Economic Research, Inc.
- Frank Lichtenberg, 2009. "The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 407-428.
- Romer, Paul M, 1990.
"Endogenous Technological Change,"
Journal of Political Economy, University of Chicago Press, vol. 98(5), pages 71-102, October.
- Paul Romer, 1989. "Endogenous Technological Change," NBER Working Papers 3210, National Bureau of Economic Research, Inc.
- Paul M Romer, 1999. "Endogenous Technological Change," Levine's Working Paper Archive 2135, David K. Levine.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Yao, Yao & Cui, Yujie & Liu, Gordon, 2026. "The intended and unintended results of medical innovation and innovation race," Technology in Society, Elsevier, vol. 85(C).
- Frank R. Lichtenberg, 2014. "The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010," Journal of Human Capital, University of Chicago Press, vol. 8(4), pages 432-480.
- Huarng, Kun-Huang & Yu, Tiffany Hui-Kuang, 2015. "Healthcare expenditure with causal recipes," Journal of Business Research, Elsevier, vol. 68(7), pages 1570-1573.
- Nishimura, Junichi & Nagaoka, Sadao & Yoneyama-Hirozane, Mariko, 2022. "The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan," Journal of the Japanese and International Economies, Elsevier, vol. 64(C).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Frank R. Lichtenberg, 2015.
"Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010,"
International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 277-299, July.
- Frank Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," CESifo Working Paper Series 5166, CESifo.
- Lichtenberg, Frank R., 2014. "The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009," Economics & Human Biology, Elsevier, vol. 13(C), pages 107-127.
- Lichtenberg, Frank R. & Tatar, Mehtap & Çalışkan, Zafer, 2014. "The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010," Health Policy, Elsevier, vol. 117(3), pages 361-373.
- Frank R. Lichtenberg, 2017. "The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia," The Economic Record, The Economic Society of Australia, vol. 93(302), pages 353-378, September.
- Nishimura, Junichi & Nagaoka, Sadao & Yoneyama-Hirozane, Mariko, 2022. "The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan," Journal of the Japanese and International Economies, Elsevier, vol. 64(C).
- Frank R. Lichtenberg, 2014.
"Has Medical Innovation Reduced Cancer Mortality?,"
CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
- Frank R. Lichtenberg, 2010. "Has medical innovation reduced cancer mortality?," NBER Working Papers 15880, National Bureau of Economic Research, Inc.
- Kuhn, Michael & Prettner, Klaus, 2016.
"Growth and welfare effects of health care in knowledge-based economies,"
Journal of Health Economics, Elsevier, vol. 46(C), pages 100-119.
- Michael Kuhn & Klaus Prettner, 2012. "Growth and Welfare Effects of Health Care in Knowledge Based Economies," VID Working Papers 1206, Vienna Institute of Demography (VID) of the Austrian Academy of Sciences in Vienna.
- Kuhn, Michael & Prettner, Klaus, 2013. "Growth and Welfare Effects of Health Care in Knowledge Based Economies," VfS Annual Conference 2013 (Duesseldorf): Competition Policy and Regulation in a Global Economic Order 79970, Verein für Socialpolitik / German Economic Association.
- Kuhn, Michael & Prettner, Klaus, 2012. "Growth and welfare effects of health care in knowledge based economies," ECON WPS - Working Papers in Economic Theory and Policy 03/2012, TU Wien, Institute of Statistics and Mathematical Methods in Economics, Economics Research Unit.
- Michael Kuhn & Klaus Prettner, 2012. "Growth and welfare e ffects of health care in knowledge based economies," Courant Research Centre: Poverty, Equity and Growth - Discussion Papers 120, Courant Research Centre PEG.
- Hostenkamp, Gisela & Lichtenberg, Frank R., 2015.
"The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence,"
Social Science & Medicine, Elsevier, vol. 130(C), pages 162-171.
- Frank Lichtenberg & Gisela Hostenkamp, 2013. "The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence," CESifo Working Paper Series 4516, CESifo.
- Lichtenberg, Frank R., 2022. "The effect of pharmaceutical innovation on longevity: Evidence from the U.S. and 26 high-income countries," Economics & Human Biology, Elsevier, vol. 46(C).
- Croce, M.M. & Nguyen, Thien T. & Raymond, S. & Schmid, L., 2019. "Government debt and the returns to innovation," Journal of Financial Economics, Elsevier, vol. 132(3), pages 205-225.
- Chu, Angus C. & Cozzi, Guido & Furukawa, Yuichi, 2016.
"Unions, innovation and cross-country wage inequality,"
Journal of Economic Dynamics and Control, Elsevier, vol. 64(C), pages 104-118.
- Chu, Angus C. & Cozzi, Guido & Furukawa, Yuichi, 2014. "Labor Unions, Directed Technical Change and Cross-Country Income Inequality," MPRA Paper 58886, University Library of Munich, Germany.
- Chu, Angus C. & Cozzi, Guido & Furukawa, Yuichi, 2015. "Unions, Innovation and Cross-Country Wage Inequality," MPRA Paper 68447, University Library of Munich, Germany.
- Schreiner, Lena & Madlener, Reinhard, 2022.
"Investing in power grid infrastructure as a flexibility option: A DSGE assessment for Germany,"
Energy Economics, Elsevier, vol. 107(C).
- Lena Schreiner & Reinhard Madlener, 2019. "Investing in power grid infrastructure as a flexibility option: A DSGE assessment for Germany," FCN Working Papers 11/2019, E.ON Energy Research Center, Future Energy Consumer Needs and Behavior (FCN).
- Bergeaud, Antonin & Schmidt, Julia & Zago, Riccardo, 2026.
"Innovation, Technology Standardization and the Value of the Firm,"
HEC Research Papers Series
1613, HEC Paris.
- Antonin Bergeaud & Julia Schmidt & Riccardo Zago, 2026. "Innovation, Technology Standardization and the Value of the Firm," Working papers 1031, Banque de France.
- Antonin Bergeaud & Julia Schmidt & Riccardo Zago, 2026. "Innovation, Technology Standardization and the Value of the Firm," Working Papers hal-05562978, HAL.
- Badibanga, Thaddée & Diao, Xinshen & Roe, Terry L. & Somwaru, Agapi, 2009.
"Dynamics of structural transformation: An empirical characterization in the case of China, Malaysia, and Ghana,"
IFPRI discussion papers
856, International Food Policy Research Institute (IFPRI).
- Badibanga, Thaddee Mutumba & Diao, Xinshen & Roe, Terry L. & Somwaru, Agapi, 2009. "Dynamics of Structural Transformation: An Empirical Characterization in the Case of China, Malaysia, and Ghana," IFPRI Discussion Papers 50004, CGIAR, International Food Policy Research Institute (IFPRI).
- Steven Bond‐Smith, 2022. "Discretely innovating: The effect of limited market contestability on innovation and growth," Scottish Journal of Political Economy, Scottish Economic Society, vol. 69(3), pages 301-327, July.
- Ahn, JaeBin & Choi, Moon Jung, 2020.
"From firm-level imports to aggregate productivity: Evidence from Korean manufacturing firm data,"
Japan and the World Economy, Elsevier, vol. 56(C).
- Mr. JaeBin Ahn & Moon Jung Choi, 2016. "From Firm-Level Imports to Aggregate Productivity: Evidence from Korean Manufacturing Firms Data," IMF Working Papers 2016/162, International Monetary Fund.
- JaeBin Ahn & Moon Jung Choi, 2016. "From Firm-level Imports to Aggregate Productivity: Evidence from Korean Manufacturing Firms Data," Working Papers 2016-6, Economic Research Institute, Bank of Korea.
- Katharina E. Blankart & Frank R. Lichtenberg, 2020. "Are patients more adherent to newer drugs?," Health Care Management Science, Springer, vol. 23(4), pages 605-618, December.
- Satyajit Chatterjee & Burcu Eyigungor, 2023.
"The Firm Size-Leverage Relationship and Its Implications for Entry and Business Concentration,"
Review of Economic Dynamics, Elsevier for the Society for Economic Dynamics, vol. 48, pages 132-157, April.
- Satyajit Chatterjee & Burcu Eyigungor, 2022. "The Firm Size-Leverage Relationship and Its Implications for Entry and Business Concentration," Working Papers 22-07, Federal Reserve Bank of Philadelphia.
- Beatriz Pereira Almeida & Eduardo Gonçalves & André Suriane Silva & Raquel Coelho Reis, 2021. "Internalization of knowledge spillovers by regions: a measure based on self-citation patents," The Annals of Regional Science, Springer;Western Regional Science Association, vol. 66(2), pages 309-330, April.
- Annarita BALDANZI & Alberto BUCCI & Klaus PRETTNER, 2016. "The Effects of Health Investments on Human Capital and R&D-Driven Economic Growth," Departmental Working Papers 2016-17, Department of Economics, Management and Quantitative Methods at Università degli Studi di Milano.
More about this item
JEL classification:
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- J11 - Labor and Demographic Economics - - Demographic Economics - - - Demographic Trends, Macroeconomic Effects, and Forecasts
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- O33 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Technological Change: Choices and Consequences; Diffusion Processes
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:taf:ecinnt:v:23:y:2014:i:3:p:239-273. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Chris Longhurst (email available below). General contact details of provider: http://www.tandfonline.com/GEIN20 .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.
Printed from https://ideas.repec.org/a/taf/ecinnt/v23y2014i3p239-273.html